The Tofts and Brix parameters Ktrans and ABrix , derived from dynamic contrast-enhanced MRI (DCE-MRI), have been suggested as potential markers of hypoxia. This phenotype is associated with poor outcome in cervical cancer treated with chemoradiotherapy. In this study, DCE-MRI was combined with immunohistochemical analysis of cervical cancer xenografts, to better understand the physiological background and prognostic potential of the parameters. Through correlations with hypoxic fraction, vascular and cellular densities, derived from pimonidazole, CD31 and hematoxylin staining of tumor sections, respectively, it was shown that ABrix could be the preferred DCE-MRI parameter for predicting hypoxia related treatment resistance in cervical cancer.
This abstract and the presentation materials are available to members only; a login is required.